OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11301	Companies
251165	Keywords
180201	Articles
137034	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 09/30/2026 at 08:00, 1 month 9 days ago

Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
Oxurion NV (Euronext Brussels: OXUR) to acquire French CRO Eclevar, expanding into MedTech CRO market. Transaction details and growth potential outlined. Exclusive negotiations aim to close by 31 December 2026

Acquisition Exclusive Negotiations Oxurion NV Eclevar MedTech CRO Market
PRESS RELEASE

published on 09/30/2026 at 08:00, 1 month 9 days ago

Oxurion entre en négociations exclusives en vue d'acquérir les activités et les actifs d'Eclevar, une CRO spécialisée dans les MedTech
Oxurion NV entre en négociations exclusives pour acquérir Eclevar, une CRO française spécialisée en dispositifs médicaux, renforçant ainsi sa position dans le marché des CRO MedTech

Acquisition Dispositifs Médicaux Oxurion NV Eclevar CRO MedTech
BRIEF

published on 09/23/2026 at 18:05, 1 month 16 days ago

Oxurion augmente ses actions avec droit de vote suite à la conversion d'obligations

Obligations Convertibles Augmentation De Capital Droit De Vote Oxurion Opportunités Spéciales Atlas
BRIEF

published on 09/23/2026 at 18:05, 1 month 16 days ago

Oxurion Increases Voting Shares Following Bond Conversion

Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 09/23/2026 at 18:00, 1 month 16 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 3 bonds in Oxurion, leading to €75,000 capital increase. Oxurion announces issuance of new shares and updated shareholder info

Shareholder Information Convertible Bonds Capital Increase Atlas Special Opportunities LLC Oxurion
PRESS RELEASE

published on 09/23/2026 at 18:00, 1 month 16 days ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 3 obligaties in Oxurion, resulterend in EUR 75.000 kapitaalverhoging. Oxurion NV publiceert informatie over de uitgifte van aandelen en conversie van obligaties

Euronext Brussel Kapitaalverhoging Atlas Special Opportunities Oxurion Converteerbare Obligaties
BRIEF

published on 09/14/2026 at 18:05, 1 month 25 days ago

Oxurion Announces Significant Tansparency Notification

Transparency Notification Share Acquisition Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II
BRIEF

published on 09/14/2026 at 18:05, 1 month 25 days ago

Oxurion annonce une importante notification de transparence

Acquisition D'actions Notification De Transparence Oxurion NV Atlas Special Opportunities II Loi Belge Sur La Transparence
PRESS RELEASE

published on 09/14/2026 at 18:00, 1 month 25 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC boven de drempel van 15% aandelen. Oxurion bouwt technologisch platform voor klinisch onderzoek en software

Transparantiekennisgeving Oxurion NV Atlas Special Opportunities II LLC Klinisch Onderzoek Technologisch Platform
PRESS RELEASE

published on 09/14/2026 at 18:00, 1 month 25 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding the holding of voting securities, crossing the threshold of 15%

Transparency Notification Euronext Brussels Oxurion NV Voting Securities Atlas Special Opportunities II LLC

Accesswire

Published on 11/10/2026 at 02:45, 4 hours 20 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 7 hours 55 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 8 hours 5 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 8 hours 33 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 8 hours 50 minutes ago

Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 06:55, 10 minutes ago

EEII AG: EEII AG et Haute Capital Partners SA concluent un accord d’exclusivité
Published on 11/10/2026 at 06:55, 10 minutes ago

EEII AG: EEII AG and Haute Capital Partners SA Enter into Exclusivity Agreement
Published on 11/10/2026 at 06:55, 10 minutes ago

Significant increase in earnings as at 30 September 2026: FFO I guidance for 2026 raised; initial guidance for 2027 points to further growth; LTV remains low
Published on 11/10/2026 at 06:30, 34 minutes ago

Quarterly results as per 30 September 2026
Published on 11/10/2026 at 06:00, 1 hour 4 minutes ago

Ad hoc announcement pursuant to Art. 53 LR 10 November 2026

Les Echos

Published on 11/10/2026 at 07:00, 5 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 12 hours 35 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 12 hours 35 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 13 hours 20 minutes ago

Weekly share buyback
Published on 11/09/2026 at 17:45, 13 hours 20 minutes ago

Déclaration hebdomadaire de rachat d'actions

View all LES ECHOS COMFI WIRE